000			01452 a2200373 4500
005			20250517230107.0
264		0	_c20190422
008			201904s 0 0 eng d
022			_a1090-2120
024	7		_a10.1016/j.bioorg.2018.07.008 _2doi
040			_aNLM _beng _cNLM
100	1		_aKassab, Asmaa E
245	0	0	_aNovel benzotriazole N-acylarylhydrazone hybrids: Design, synthesis, anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis and FAK inhibition. _h[electronic resource]
260			_bBioorganic chemistry _c10 2018
300			_a531-544 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAntineoplastic Agents _xchemical synthesis
650	0	4	_aApoptosis _xdrug effects
650	0	4	_aCaspase 3 _xmetabolism
650	0	4	_aCell Cycle _xdrug effects
650	0	4	_aCell Line, Tumor
650	0	4	_aCell Proliferation _xdrug effects
650	0	4	_aDrug Design
650	0	4	_aDrug Screening Assays, Antitumor
650	0	4	_aFocal Adhesion Protein-Tyrosine Kinases _xantagonists & inhibitors
650	0	4	_aHumans
650	0	4	_aHydrazones _xchemical synthesis
650	0	4	_aMolecular Docking Simulation
650	0	4	_aNeoplasms _xdrug therapy
650	0	4	_aTriazoles _xchemical synthesis
700	1		_aHassan, Rasha A
773	0		_tBioorganic chemistry _gvol. 80 _gp. 531-544
856	4	0	_uhttps://doi.org/10.1016/j.bioorg.2018.07.008 _zAvailable from publisher's website
999			_c28639128 _d28639128